| ²é¿´: 1052 | »Ø¸´: 6 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
ΪÄãÇ鶯½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
°ïæ·ÒëÒ»¶ÎÕªÒª£¬Ð»Ð»
|
|
|
Ö÷¶¯°ÐÏò¸øÒ©ÖÎÁƷΰ©µÄÑо¿½øÕ¹¡£Ä¿Ç°£¬Íâ¿ÆÕïÁƼ¼Êõ¼°»¯ÁÆ¡¢·ÅÁƵÈ×÷Ϊ·Î°©µÄÖ÷ÒªÖÎÁÆÊֶΣ¬ËäÈ»¶Ô·Î°©µÄÖÎÁÆÆðµ½Ò»¶¨Ð§¹û£¬µ«¶Ô»¼Õß³¤ÆÚÉú´æµÄ¸ÄÉÆ³Ì¶È½ÏС¡£°ÐÏòÖÎÁƼ¼ÊõÒòÆä°²È«¡¢¸ßЧ¡¢µÍ¶¾µÄÖÎÁÆÐ§¹û¶ø³ÉΪµ±Ç°·Î°©Ñо¿µÄÈȵãÖ®Ò»¡£±¾ÎĽéÉÜÁËĿǰÖ÷¶¯°ÐÏòÖÎÁƷΰ©¹ý³ÌÖеĸ÷Àà°Ð·Ö×Ó¼°°ÐÏòºÍżÁª»úÀí£¬²ûÊöÁËÅäÌå-ÊÜÌå½éµ¼¡¢¿¹Ô-¿¹Ìå½éµ¼Ôڷΰ©°ÐÏòÖÎÁÆÖеÄÑо¿½øÕ¹¡£×îºó£¬¶ÔÆäÁÙ´²Ó¦ÓýøÐÐÁËÕ¹Íû¡£ @wenzi6337 |
» ²ÂÄãϲ»¶
317·Ö Ò»Ö¾Ô¸ÄÏÀí¹¤²ÄÁϹ¤³Ì ±¾¿Æºþ¹¤´ó Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ4È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶£¬×Ü·Ö289·Ö
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Î人Àí¹¤£¬×Ü·Ö321£¬Ó¢Ò»Êý¶þ£¬ÇóÀÏʦÊÕÁô¡£
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸±±»¯Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ6È˻ظ´
318Ò»Ö¾Ô¸¼ªÁÖ´óѧÉúÎïÓëÒ½Ò© Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
һ־Ը˫һÁ÷»úе285·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´

lan321
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1261.3
- ºì»¨: 3
- Ìû×Ó: 149
- ÔÚÏß: 40.4Сʱ
- ³æºÅ: 989721
- ×¢²á: 2010-04-05
- ÐÔ±ð: GG
- רҵ: ÆäËûÎÞ»ú·Ç½ðÊô²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
sltmac: ½ð±Ò+1 2012-07-11 13:16:17
ΪÄãÇ鶯: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, ллÄã°¡£¬·ÒëµÄÒ²²»´í£¬²»¹ýÓеÀºÃÏñ¾ÍÕâô·ÒëµÄ£¬»¹ÊÇллÁË 2012-07-11 22:32:43
ΪÄãÇ鶯: ½ð±Ò+5, ллÀ² 2012-07-11 22:34:50
sltmac: ½ð±Ò+1 2012-07-11 13:16:17
ΪÄãÇ鶯: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, ллÄã°¡£¬·ÒëµÄÒ²²»´í£¬²»¹ýÓеÀºÃÏñ¾ÍÕâô·ÒëµÄ£¬»¹ÊÇллÁË 2012-07-11 22:32:43
ΪÄãÇ鶯: ½ð±Ò+5, ллÀ² 2012-07-11 22:34:50
| Active targeting of drug treatment for lung cancer research progress. At present, surgical treatment techniques and chemotherapy, and radiotherapy as the main treatment of lung cancer, the treatment of lung cancer play a certain effect, but a smaller degree of improvement in patients with long-term survival. Targeted therapy technology because of its safe, efficient, and low toxicity of the treatment effect and become one of the hotspots of the current lung cancer research. This article describes the various types of target molecules in the active targeted therapy of lung cancer process and targeting and coupling mechanism, described the progress of the ligand - receptor-mediated, antigen - antibody-mediated targeted therapy of lung cancer. Finally, the clinical application prospect. |

2Â¥2012-07-10 20:31:57
ΪÄãÇ鶯
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 393.4
- É¢½ð: 10
- ºì»¨: 16
- ɳ·¢: 3
- Ìû×Ó: 824
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 1398029
- ×¢²á: 2011-09-11
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ó×é×°Ó볬·Ö×ӽṹ

3Â¥2012-07-11 10:25:38
ΪÄãÇ鶯
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 393.4
- É¢½ð: 10
- ºì»¨: 16
- ɳ·¢: 3
- Ìû×Ó: 824
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 1398029
- ×¢²á: 2011-09-11
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ó×é×°Ó볬·Ö×ӽṹ

4Â¥2012-07-11 14:43:37
wenzi6337
ľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 6
- Ó¦Öú: 27 (СѧÉú)
- ½ð±Ò: 3267.6
- É¢½ð: 196
- ºì»¨: 7
- ɳ·¢: 1
- Ìû×Ó: 1364
- ÔÚÏß: 413.8Сʱ
- ³æºÅ: 716576
- ×¢²á: 2009-03-06
- ÐÔ±ð: GG
- רҵ: Ö²ÎïÉúÀíÓëÉú»¯
5Â¥2012-07-11 18:27:56
guo2010
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 2
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 493.1
- Ìû×Ó: 81
- ÔÚÏß: 51.1Сʱ
- ³æºÅ: 1194909
- ×¢²á: 2011-01-23
- רҵ: ¿¹Ñ×ÓëÃâÒßÒ©ÎïÒ©Àí
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ΪÄãÇ鶯: ½ð±Ò+30, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£¸Ðл£¬Õâ¸ö·ÒëͦºÃµÄ 2012-07-11 22:31:44
ΪÄãÇ鶯: ½ð±Ò+30, ·ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ·Ç³£¸Ðл£¬Õâ¸ö·ÒëͦºÃµÄ 2012-07-11 22:31:44
|
ÎÒ×Ô¼ºË®Æ½ÓÐÏÞ,½«¶þÂ¥¾õµÃÐèÒªÐ޸ĵĵط½½øÐÐÁËÐÞ¸Ä.¿ÉÒԲο¼O(¡É_¡É)O~ Active targeting of drug treatment for lung cancer research progress. At present, the main treatments of lung cancer are surgical treatment techniques, chemotherapy and radiotherapy, which play a certain effect, but a smaller degree of improvement in patients with long-term survival. Targeted therapy technology, because of its safety, availabilityand low toxicity, has become one of the hotspots of the current lung cancer research. This article describes various types of target molecules in the active targeted therapy of lung cancer process and targeting and coupling mechanism, and also describs the progress of the ligand - receptor-mediated, antigen - antibody-mediated targeted therapy of lung cancer. Finally, the clinical application prospect. |
6Â¥2012-07-11 21:53:16
ΪÄãÇ鶯
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 393.4
- É¢½ð: 10
- ºì»¨: 16
- ɳ·¢: 3
- Ìû×Ó: 824
- ÔÚÏß: 53.4Сʱ
- ³æºÅ: 1398029
- ×¢²á: 2011-09-11
- ÐÔ±ð: MM
- רҵ: ¸ß·Ö×Ó×é×°Ó볬·Ö×ӽṹ

7Â¥2012-07-11 22:34:24














»Ø¸´´ËÂ¥
Çó·Ò룬»ò°Ñ¶þÂ¥µÄ·Òë¸ÄµÄÍêÃÀһЩ£¬½ð±Ò¿ÉÒÔÔÙ¼Ó°¡£¬Çó¸÷λÁË